- Home
- EVT vs NEO Comparison
EVT vs NEO Comparison
Compare EVT & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVT
- NEO
- Stock Information
- Founded
- EVT 2003
- NEO 2001
- Country
- EVT United States
- NEO United States
- Employees
- EVT N/A
- NEO N/A
- Industry
- EVT Finance Companies
- NEO Precision Instruments
- Sector
- EVT Finance
- NEO Health Care
- Exchange
- EVT Nasdaq
- NEO Nasdaq
- Market Cap
- EVT 1.8B
- NEO 2.1B
- IPO Year
- EVT N/A
- NEO 1999
- Fundamental
- Price
- EVT $25.06
- NEO $15.04
- Analyst Decision
- EVT
- NEO Strong Buy
- Analyst Count
- EVT 0
- NEO 9
- Target Price
- EVT N/A
- NEO $19.89
- AVG Volume (30 Days)
- EVT 121.5K
- NEO 792.3K
- Earning Date
- EVT 01-01-0001
- NEO 11-05-2024
- Dividend Yield
- EVT 7.72%
- NEO N/A
- EPS Growth
- EVT N/A
- NEO N/A
- EPS
- EVT N/A
- NEO N/A
- Revenue
- EVT N/A
- NEO $644,118,000.00
- Revenue This Year
- EVT N/A
- NEO $12.93
- Revenue Next Year
- EVT N/A
- NEO $9.70
- P/E Ratio
- EVT N/A
- NEO N/A
- Revenue Growth
- EVT N/A
- NEO 12.06
- 52 Week Low
- EVT $18.70
- NEO $12.77
- 52 Week High
- EVT $23.82
- NEO $21.22
- Technical
- Relative Strength Index (RSI)
- EVT 63.17
- NEO 52.58
- Support Level
- EVT $25.03
- NEO $13.35
- Resistance Level
- EVT $25.30
- NEO $16.60
- Average True Range (ATR)
- EVT 0.21
- NEO 0.67
- MACD
- EVT 0.08
- NEO 0.18
- Stochastic Oscillator
- EVT 85.61
- NEO 53.98
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.
About NEO NeoGenomics Inc.
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Advanced Diagnostics. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. Advanced Diagnostics segment supports pharmaceutical firms in their drug development programs by supporting various clinical trials and research. For Clinical Services, Its specialized diagnostic services are performed based on an online test order or a written test requisition form. The company generates majority of its revenue from Clinical Services.